Related Experiment Video
Updated: Apr 5, 2026

Author Spotlight: Exploring the Impact of Reduced Resistance Exercise Volume on Metabolic Health
Published on: December 1, 2023
Improving diabetes outcomes through lifestyle change--A randomized controlled trial
Linda M Delahanty1,2, Kristen M Dalton1, Bianca Porneala3
1Department of Medicine, Massachusetts General Hospital Diabetes Center, Boston, Massachusetts, USA.
A group lifestyle intervention (GLI) for type 2 diabetes patients led to greater weight loss and reduced medication use compared to dietitian referral for medical nutrition therapy (RD). This affordable GLI is effective in primary care settings.
Area of Science:
- Endocrinology
- Metabolic Diseases
- Public Health
Background:
- Type 2 diabetes management often requires lifestyle interventions for weight loss.
- Dietitian referral for medical nutrition therapy (RD) is a common approach.
- Group lifestyle interventions (GLI) offer a potentially scalable alternative.
Purpose of the Study:
- To compare the effectiveness of a GLI versus RD for weight loss in type 2 diabetes patients.
- To evaluate changes in glycemic control, medications, and cardiac risk factors.
- To conduct a cost analysis of the GLI program.
Main Methods:
- A randomized clinical trial involving 57 primary care patients with type 2 diabetes and BMI >25 kg/m².
- Participants were assigned to either a 19-week dietitian-led GLI or RD.
- Outcome measures included weight loss at 6 months and 1 year, medication changes, glycemic control, and cost.
Main Results:
- At 6 months, 46% of GLI participants lost ≥5% body weight compared to 21% in RD (P=0.04).
- Mean weight loss was significantly greater in GLI (6.6 kg) vs. RD (2.1 kg) at 6 months (P=0.004) and sustained at 1 year.
- 82% of GLI participants reduced or stopped diabetes medications vs. 38% in RD (P<0.001).
Conclusions:
- An affordable group lifestyle intervention (GLI) is more effective than dietitian referral for medical nutrition therapy (RD) for weight loss in type 2 diabetes patients.
- GLI promotes significant medication reduction in this population.
- GLI represents a cost-effective intervention for type 2 diabetes management in primary care.
Related Concept Videos
Diabetes: Management and Pharmacotherapy
Insulin remains the cornerstone of treatment for most patients with type 1 and many...
Diabetes Mellitus: Type 2 and Gestational
Diabetes Mellitus: Overview and Type I Subtype
Type 1 diabetes is an autoimmune disease in which the immune system mistakenly attacks and destroys the insulin-producing beta cells in the pancreas. As a result, the body is unable to produce sufficient insulin, and individuals with...
Atherosclerosis III: Management
Hypertension IV: Drug Therapy and Lifestyle Modifications
Carbohydrate Metabolism
Starch accounts for approximately 60% of the carbohydrates consumed by humans. Since amylase enzymes cannot function in the stomach's acidic environment, starch can only be digested in the mouth and small intestine. Simple sugars are found naturally in milk and fruits in...

